Skip to main content
Glama

Tiingo

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark this as read-only, idempotent, and non-destructive. The description adds substantial behavioral detail beyond that: graceful degradation when LEI/FIGI sources fail, ambiguous matches returning figi_candidates, unresolved identifiers explicitly surfaced, and the internal cascade across multiple lookup endpoints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with trigger phrases and the core instruction, which is good. It is long and dense, with the company type buried inside a large parenthetical, but nearly every clause carries useful operational detail so it earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description covers expected return behavior well: what identifiers are produced per type, what happens on ambiguous matches, what happens when enrichment sources are down, and how unresolved IDs are handled. There is no significant missing context for an agent selecting or invoking the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds meaning well beyond the parameter names and enum values. It explains accepted input forms for type=company (ticker, CIK, ISIN, or name), clarifies that ISIN resolves to a legal entity via the LEI mapping, and warns against passing full noun phrases by showing a bond issuer example.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb and resource: resolve a user-spoken name to canonical/official identifiers that other tools need. It is differentiated from likely siblings by positioning itself as the name-to-ID entry point, and the concrete query examples make its purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly states the primary usage condition: "Use FIRST whenever you have a name but need an ID." It does not name alternatives or give when-not-to-use guidance, but the context is clear enough for selecting this tool in most cases.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Tiingo toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tools have overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded differ only in mode; several Polymarket tools (polymarket_arbitrage, polymarket_edges, polymarket_fill_risk, bet_research) target related opportunities; ai_visibility_check and scan_competitor_ai_presence overlap. The meta-tools (discover_tools, suggest_questions, pipeworx_trending) could also be confused for one another.

Naming Consistency3/5

All names are lowercase snake_case, which is consistent, but patterns vary: some are verb_noun (ask_pipeworx, resolve_entity, validate_claim), others are noun (news, crypto_prices, stock_metadata), and several use brand prefixes (pipeworx_*, polymarket_*). This mixed convention is readable but not predictable.

Tool Count2/5

35 tools is too many for a coherent, well-scoped server. The set bundles a financial data API (Tiingo) with a generic data router (ask_pipeworx), prediction-market tools, memory utilities, subscription management, and npm checks — many unrelated to the server's apparent purpose, making it feel bloated.

Completeness2/5

For a Tiingo server, core data coverage is limited to stock prices, stock metadata, crypto prices, and news — missing real-time quotes, fundamentals, forex, technical indicators, and other typical Tiingo endpoints. Conversely, the general Pipeworx platform has broad query/research/subscription coverage but that domain doesn't align with the server name, leaving significant functional gaps.

Resources